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Adaptive Foxp3+ regulatory T (Treg) cells develop
during induction of mucosal tolerance and after
immunization. Large numbers of Foxp3+ T cells
have been found in inflamed tissues.We investigated
the role of adaptive Foxp3+ Treg cells in mucosal tol-
erance and in chronic allergic lung inflammation. We
used two strains of mice that are devoid of naturally
occurring Treg cells; one is capable of generating
adaptive Foxp3+ Treg cells upon exposure to anti-
gen, whereas the other is deficient in both naturally
occurring and adaptive Foxp3+ Treg cells. We found
that adaptive Foxp3+ Treg cells were essential for
establishing mucosal tolerance and for suppressing
IL-4 production and lymphoid neogenesis in chronic
inflammation, whereas IL-5 production and eosino-
philia could be controlled by Foxp3-independent,
IFN-g-dependentmechanisms. Thus, whereas adap-
tive Foxp3+ Treg cells regulate sensitization to aller-
gens and the severity of chronic inflammation,
IFN-g-producing cells can play a beneficial role in
inflammatory conditions involving eosinophils.
INTRODUCTION
Immunological tolerance to inhaled environmental allergens pro-
tects individuals from developing pathological responses in the
airways and lungs. Failures in the mechanisms of tolerance
lead to the sensitization to allergens and to inflammatory reac-
tions such as allergic asthma. Allergic asthma is characterized
by production of T helper 2 (Th2) cytokines, IgE antibodies,
eosinophilic lung inflammation, bronchial hyper-responsiveness,
and lung remodeling (Wills-Karp, 1999)(Cohn et al., 2004).
Th2 cell-mediated allergic reactions can be prevented by
CD4+ regulatory T cells (Curotto de Lafaille et al., 2001). Naturally
occurring CD4+ Treg cells express Foxp3 (Fontenot et al., 2003;
Hori et al., 2003; Khattri et al., 2003), develop in the thymus, and
migrate to the peripheral lymphoid organs (Shevach et al., 2006).
It is now clear that Foxp3+ Treg cells phenotypically indistin-
guishable from naturally occurring Treg cells can also develop
in the periphery under a number of conditions (Apostolou and
von Boehmer, 2004; Cobbold et al., 2004; Curotto de Lafaille114 Immunity 29, 114–126, July 18, 2008 ª2008 Elsevier Inc.et al., 2004;Mucida et al., 2005). In vitro, naive T cells can convert
to Foxp3+ cells by stimulation in the presence of TFG-b and IL-2
(Chen et al., 2003; Zheng et al., 2007). In mice and humans,
deficiency in Foxp3 causes spontaneous autoimmunity with
multi-organ inflammation and early death (Bennett et al., 2001;
Chatila et al., 2000). Foxp3 deficiency also leads to increased
atopy (Lin et al., 2005).
Previously, we studied T cell differentiation during oral-toler-
ance induction in mice that harbor a monoclonal CD4+ T popula-
tion specific for chicken ovalbumin (OVA) and that lack naturally
occurring Treg cells. We found that OVA-specific Foxp3+ Treg
cells were induced upon addition of OVA to the drinking water.
Tolerant mice were protected against immunization with OVA
in adjuvants, whereas naivemice became sensitized; they devel-
oped a Th2 response, IgE antibodies, and allergic inflammation
(Mucida et al., 2005). Intriguingly, OVA-specific Foxp3+ Treg
cells were also induced, alongside Th2 cells, by immunization
of naive mice with adjuvants; the role of these immunization-
induced Treg cells is not clear because they obviously do not
prevent the primary allergic response.
Although the name ‘‘adaptive’’ Treg cells is mostly used in ref-
erence to Foxp3-negative regulatory T cells such as Tr1 cells
(Levings et al., 2005; Vieira et al., 2004), here we refer to
mucosa-induced and immunization-induced Foxp3+ Treg cells
as adaptive Foxp3+ Treg cells to indicate that these cells arise
from naive Foxp3 T cells that were not selected in the thymus
as naturally occurring Foxp3+ Treg cells. Despite the strong cor-
relation between immunological tolerance and allergen-driven
induction of Foxp3+ Treg cells, it is not known whether adaptive
Foxp3+ Treg cells are essential for mucosal tolerance or whether
other redundant tolerance mechanisms operate as well.
The presence of large numbers of Foxp3+ Treg cells in situa-
tions of severe inflammation also remains unexplained. Although
it has become increasingly clear that Treg cells affect all types of
Th-mediated responses, including those against foreign anti-
gens and allergens, there is an apparent paradox, which is that
large numbers of Treg cells are found at sites of ongoing chronic
inflammation (Ruprecht et al., 2005; Saruta et al., 2007; Sasaki
et al., 2007; Smyth et al., 2007; van Amelsfort et al., 2004). It is
unclear whether in chronic inflammation these Treg cells are
unable to carry out their function, whether they are overwhelmed
or neutralized, or even whether they contribute to the pathology,
for instance by secreting TGF-b that is important in fibrosis. In
acute allergic inflammation, antibody depletion of CD25+ cells
had a worsening effect in one of two mouse strains tested
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Treg cells correlated inversely with the severity of allergic inflam-
mation in a rat model of asthma (Strickland et al., 2006), an indi-
cation that Treg cells might modulate lung inflammation.
To obtain unambiguous evidence for a role of adaptive Foxp3+
Tregcells inmucosal toleranceandchronic allergic inflammation,
we compared mice that lack naturally occurring Treg cells but
have the capacity to generate adaptive Foxp3+ Treg cells with
mice that lack naturally occurring Treg cells and also lack the ca-
pacity to generate adaptive Treg cells as a result of a deficiency in
the Foxp3 gene. Our results show that the induction of adaptive
Foxp3+ Treg cells is essential to establish mucosal tolerance by
the oral and respiratory routes. Using a model of chronic allergic
inflammation, we demonstrate the existence of Foxp3-depen-
dent and -independent suppressivemechanisms. Althoughover-
all disease severity and IL-4 mediated pathology was strongly
dependent on Foxp3+ Treg cells, the suppression of IL-5 produc-
tion and eosinophilia largely occurred in a Foxp3-independent,
IFN-g-dependent manner. Thus, increased Foxp3+ Treg function
is expected to benefit all inflammatory conditions, but specific
cytokine therapy might apply to particular types of inflammation.
RESULTS
The Role of Adaptive Foxp3+ Treg Cells in Mucosa-
Induced Immunological Tolerance
T-Bmonoclonal mice (T-Bmc) have non-self-reactive repertoires
of T and B cells. In thesemice, all T cells (DO11.10 T cell receptor
[TCR] transgenic) recognize chicken ovalbumin (OVA), and all
B cells (17/9 IgH and IgL knock-in) recognize a peptide from
influenza hemagglutinin (HA). The T and B cell repertoires are
monoclonal because of the crossing with Rag-1-deficient mice
(Curotto de Lafaille et al., 2001). Like all monoclonal T cell
receptor-transgenic mice described thus far, T-Bmc lack natu-
rally occurring Foxp3+ Treg cells (Mucida et al., 2005; Shen
et al., 2005). We showed previously that the oral administration
of OVA to T-Bmc mice resulted in immunological tolerance,
which correlated with the induction of antigen-specific adaptive
Foxp3+CD25+ Treg cells. To ensure that the observed conver-
sion of Foxp3 into Foxp3+ cells in OVA-fed T-Bmc mice was
not an artifact caused by the very high frequency of OVA-specific
T cells in T-Bmc mice, we transferred bone marrow from T-Bmc
mice to wild-type BALB/c recipient mice. In the resulting chi-
meras, the proportion of OVA-specific Rag-deficient T cells
was less than 2% of the T cells, and the vast majority of the T
cells were polyclonal wild-type cells of host origin. Importantly,
in these chimeras we also observed the ‘‘de novo’’ expression
of Foxp3 in donor-derived OVA-specific cells after OVA feeding,
whereas no conversion occurred in controls that did not received
OVA (Figure S1 in the Supplemental Data).
Foxp3-deficientscurfymicedevelopa fulminating inflammatory
disease and die at about the age of weaning (Kanangat et al.,
1996). To study the role of adaptiveFoxp3+ regulatory T cellswith-
out the influence of the imminent inflammatory disease, we
crossed scurfy mice with T-Bmc mice, whose monoclonal T and
B lymphocytes do not recognize self- or environmental antigens.
In the absence of deliberate antigen exposure, lymphocytes in
the T-Bmc Foxp3sf mice had a naive phenotype, and dendritic
cells did not show signs of spontaneous activation (Figure S2).To determine whether Foxp3+ Treg cells were absolutely
required for mucosa-induced tolerance, we compared T-Bmc
Foxp3sf mice with littermates carrying normal Foxp3 genes
(T-Bmc Foxp3wt). We first tested whether administration of
OVA by oral or intranasal mucosal routes to T-Bmc Foxp3sf
mice would prevent an allergic response to subsequent immuni-
zation with antigen (OVA-HA) in alum (Figure 1A). To determine
whether the mice had become sensitized and capable of devel-
oping allergic lung inflammation, OVA-HA was subsequently
instilled by intranasal route (Figure 1A).
T-Bmc mice carrying the mutated Foxp3 gene failed to
develop mucosa-induced tolerance to OVA, as demonstrated
by the high IgE levels in sera of T-Bmc Foxp3sfmice that received
oral or intranasal OVA before immunization (Figure 1B). In
contrast, IgE concentrations were 99% lower in similarly treated
T-Bmc Foxp3wt mice. Furthermore, IgE values were as high in
T-Bmc Foxp3sf mice given mucosal OVA as in animals not given
mucosal OVA (Figure 1B), suggesting that in this experimental
setup mucosal tolerance can be fully accounted for by Foxp3-
dependent pathways. Interestingly, immunized T-Bmc Foxp3wt
and Foxp3sf mice not previously given OVA through mucosa
developed similarly high IgE responses (Figure 1B). Similar con-
clusions were reached with other inflammation readouts. Cells
obtained from broncho-alveolar lavage (BAL) of T-Bmc Foxp3sf
mice pretreated with oral or intranasal OVA before immunization
produced IL-4, whereas IL-4 production was suppressed in
T-Bmc Foxp3wt mice (Figure 1C). Quantification of eosinophils
in the BAL revealed intense eosinophilic inflammation in Foxp3sf
mice but not in T-Bmc Foxp3wt mice administered oral or nasal
OVA before immunization (Figure 1D). The failure of mucosal
tolerance in T-Bmc Foxp3sf mice was also illustrated by the un-
restrained development of germinal centers and class switching
in spleen and lymph nodes (Figure S3).
Foxp3 expression was detected in BAL cells of tolerant and al-
lergic Foxp3wt mice, demonstrating that Foxp3+ Treg cells were
induced after antigen treatment and localized to the airways after
intranasal challenge (Figures 1E and 1F). The induction of OVA-
specific adaptive Foxp3+ Treg cells and immunological tolerance
in this model did not require the thymus in light of the fact that it
occurred in thymectomized animals (Figure S4).
To confirm that the phenotype of the T-Bmc Foxp3sfmice was
solely the consequence of their T cell defect, we transferred
naive OVA-specific T cells from Foxp3wt mice to T-Bmc Foxp3sf
mice. The recipient mice were subsequently administered OVA
in drinking water for 5 days and then immunized with OVA-HA
in alum. Two weeks after immunization, the concentration of
IgE antibodies in serum was determined. As anticipated, the
transfer of T cells from T-Bmc Foxp3wt mice could complement
the tolerance defect of T-Bmc Foxp3sf mice (Figure S5).
Altogether, these experiments demonstrate that Foxp3-ex-
pressing T cells are essential for extablishing immunological tol-
erance through the intestine and the airways and that other
(Foxp3-independent) tolerance mechanisms play little or no role.
Adaptive Foxp3+ Treg Cells Display High Basal
Proliferation and a Rapid Increase of Inflammation
The observation that Treg cells are induced by immunization
(Mucida et al., 2005), and that they represent a higher proportion
of CD4+ cells in the inflamed airways than in the lymphoid organsImmunity 29, 114–126, July 18, 2008 ª2008 Elsevier Inc. 115
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Adaptive Foxp3+ Treg Cells in Allergic InflammationFigure 1. Mucosal Tolerance Is Impaired in Foxp3-Deficient Mice
(A) Protocol for inducing mucosal tolerance to allergic sensitization. T-Bmcmice were pretreated with OVA in the drinking water for 5 days (7 to2) or with OVA
intranasally for 3 days (7 to 5). Mice were then immunized by intraperitoneal (i.p.) injection of OVA-HA in alum (day 0). Lung inflammation was induced by
intranasal (i.n.) administration of OVA-HA on days 14, 17, and 21. Analysis was performed one day after.
(B) Serum concentration of IgE on day 22. The data are average + SD of 8–16 mice per group.
(C) Expression of IL-4 mRNA in total BAL cells from day 22 as determined by quantitative PCR (Q-PCR). Average + SD of 3–7 mice per group.
(D) Eosinophils (Eo) in BAL were identified by flow cytometry as MHC II, CCR3+, Gr1 intermediate cells. The left panel shows representative dot plots of gated
MHC II BAL cells. Eosinophil numbers in BAL are shown in the bar graphic on the right. The data are the averages + SD of 3–4 mice per group and are repre-
sentative of three independent experiments.
(E) Expression of Foxp3 mRNA in total BAL cells from day 22 as determined by Q-PCR. Shown are averages + SD of 3–7 mice per group.
(F) Identification of Foxp3+CD4+ cells in immunized and airway-challenged mice. Flow cytometry of BAL and spleen cells from T-Bmc mice that had been
immunized and challengedwithOVA-HA through the airways and from untreatedmice. Representative dot plots show the expression of Foxp3 andCD25 in gated
CD4+ cells.
**p% 0.01; *p% 0.05.116 Immunity 29, 114–126, July 18, 2008 ª2008 Elsevier Inc.
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cell proliferation and accumulation before and after intranasal
challenge. Comparative analysis was carried out for
Foxp3CD4+ cells.
T-Bmc mice were immunized with OVA-HA in alum by intra-
peritoneal route, and 2–3 weeks later they received intranasal
Figure 2. Accumulation of Foxp3+ CD4+
Cells during the Onset of Allergic Inflamma-
tion in the Lung
T-Bmc Foxp3wt mice were immunized intraperito-
neally with OVA-HA in alum and 2weeks later were
administered 10 mg OVA-HA intranasally. Mice
were injected with BrdU 6 hr before analysis.
BAL, lung, LN, and spleen cells were harvested
from untreatedmice, immunized but unchallenged
(Imm), and immunized and challenged (Imm i.n.)
mice 1, 2, and 3 days after i.n. challenge. Values
shown in (A), (B), and (E) are average + SD of
data compiled from four independent experiments
(n = 5 untreated; n = 8 Imm i.n. day 0; n = 9 Imm i.n.
day 1; n = 9 Imm i.n. day 2; n = 2 Imm i.n. day 3).
(A) Kinetics of inflammation in the lung after intra-
nasal administration of antigen. The numbers of
total cells, CD4+ cells, and CD4+Foxp3+ cells in
BAL and lungs of mice during the onset of allergic
inflammation are shown.
(B) Changes in the percentage of Foxp3+ cells
among the CD4+ population of tissues and lym-
phoid organs during the onset of lung inflamma-
tion. BAL, lung, thoracic LN, spleen, and inguinal
LN were analyzed.
(C) Paucity of Fox3+ cells in the airways of immu-
nized mice with no lung inflammation. T-Bmc
Foxp3gfp.KI mice were immunized with OVA-HA
in alum and were or were not administered OVA-
HA intranasally twice. Flow-cytometric analysis
was performed 1 day after the last intranasal chal-
lenge. Representative plots show Foxp3-GFP ex-
pression in gated CD4+ cells.
(D) CD4+ cells in the BAL of immunized but unchal-
lenged mice have an activated and memory phe-
notype. Expression of CD25 and CD45RB in
CD4+ cells from BAL and lungs of untreated, im-
munized but unchallenged (Imm), and immunized
and challenged (Imm i.n. Chall) T-Bmc mice. Rep-
resentative flow histograms of gated CD4+ cells
are shown.
(E) BrdU incorporation in CD4+Foxp3+ and
CD4+Foxp3 cells of tissues and lymphoid organs
during the onset of allergic inflammation. Repre-
sentative flow plots of BrdU staining are shown
in Figure 6S.
OVA-HA. Figure 2A shows the kinetics
of cellular accumulation in the lungs and
airways of immunized mice before and
after single intranasal administration of
antigen. Very few T cells were present in
the BAL of untreated T-Bmc mice. Total
infiltrating cells, CD4+ cells, and Foxp3+
Treg cells peaked in the lungs and air-
ways 2 days after intranasal challenge.
As inflammation developed, Foxp3+CD4+
cells became more prominent; they had increased 13-fold in the
lungs and more than 100-fold in the BAL by the second day after
intranasal challenge. In comparison, CD4 cells increased 4-fold
in the lungs and 14-fold in the BAL, and the increase in total cells
was even lower (Figure 2A). Thus, there was an enrichment of
Treg cells in lungs and airways as the inflammation progressed.Immunity 29, 114–126, July 18, 2008 ª2008 Elsevier Inc. 117
Immunity
Adaptive Foxp3+ Treg Cells in Allergic InflammationComparison of the frequencies of the different CD4+ T cell sub-
sets in lungs, airways, and lymphoid organs showed that, on
average, inflamed lungs and airways contained the highest
percentage of Foxp3+ cells (Figure 2B).
It was interesting to observe the relative paucity of Foxp3+
cells within the BAL population from immunized mice that had
not been administered intranasal antigen. In these mice, (indi-
cated as ‘‘0’’ in Figure 2), the percentage of Foxp3+ within
CD4+ cells was much lower in the BAL than in the lungs, LN, or
spleen. This is further illustrated in Figure 2C by the analysis of
BAL, lung, and spleen CD4+ cells from Foxp3gfp.KI reporter
T-Bmc mice. After intranasal challenge, the percentage of GFP+
cells increased dramatically in the BAL, consistent with the
results shown in Figure 2B.
BAL CD4+ cells in immunized but unchallenged mice had an
activated andmemory CD25+CD45RBlow phenotype (Figure 2D).
In contrast, CD4+ cells recovered from the lungs of the same
mice showed a resting phenotype containing low numbers of
CD25+ and CD45RBlow cells, and a percentage of Foxp3+ cells
similar to lymphoid organs. Thus, although conventional memory
CD4+ T cells were able to cross the lung epithelial barrier under
noninflammatory local conditions, adaptive Foxp3+ Treg cells
were less able to do so and required further antigen stimulation
to reach the airway space.
To determine the proliferation rates of Foxp3+ and
Foxp3CD4+ cells in tissues and lymphoid organs, we analyzed
BrdU incorporation (Figure 2E and Figure S6). Spleen and LN
Foxp3+ cells from immunized mice incorporated BrdU at higher
rates than Foxp3CD4+ before and after intranasal challenge. In
lungs of immunized but unchallenged mice, approximately 10%
of Foxp3+ cells were labeled with BrdU, but less than 2% of
Foxp3CD4+ cells were thus labeled. Intranasal challenge
caused a 12-fold increase in the percentage of BrdU+ cells within
the Foxp3CD4+ cells of the lungs, but less than a 2-fold in-
crease in the percentage of BrdU+ Foxp3+ cells. In draining tho-
racic LN, BrdU incorporation increased 3.9-fold in Foxp3CD4+
cells and 2.4-fold in Foxp3+ cells (Figure 2E). The increase in the
proliferation rate of Foxp3+CD4+ T cells was rather unremarkable
at the time in which Treg numbers were increasing dramatically.
These data can be explained by an increased conversion of
Foxp3CD4+ cells into Foxp3+ cells in situ within the lung tissue,
although other scenarios are also possible.
In sum, we showed that the development of allergic lung in-
flammation is accompanied by a preferential accumulation of
Foxp3+ Treg cells in lungs and airways and that adaptive
Foxp3+CD4+ T cells have a higher basal level of proliferation
than Foxp3CD4+ cells in immunized mice.
Oral OVA Alone Does Not Induce Effector Th Cell
Differentiation in T-Bmc Foxp3sf Mice
It has been known for a long time that antigen administration
through mucosal routes results in immunological tolerance. We
reported that oral tolerance in T-Bmc Foxp3wt mice correlated
with the generation of Foxp3+ Treg cells (Mucida et al., 2005).
We then asked whether the administration of oral OVA per se
would induce the differentiation of CD4+ Th effector cells when
Foxp3+ Treg cells could not be generated. To this end, we fed
OVA to T-Bmc mice with either wild-type or scurfy Foxp3 genes
and studied the activation and effector functions of their mesen-118 Immunity 29, 114–126, July 18, 2008 ª2008 Elsevier Inc.teric LN T cells (Figure 3A). Two days after the oral OVA treat-
ment, the early activation marker CD69 was similarly upregu-
lated in T cells from T-Bmc Foxp3wt or T-Bmc Foxp3sf mice
(47% and 44% of CD69+ cells among OVA-specific T cells, re-
spectively). Far fewer OVA-specific T cells expressed CD25 or
CD103 at the same time point (Figure 3B). A population of
OVA-specific T cells coexpressing Foxp3, CD25, and CD103
was induced in Foxp3wt mice but not in Foxp3sf mice
(Figure 3B). After OVA treatment, 1%–2% of OVA-specific cells
expressed Foxp3 in the mesenteric LN of T-Bmc Foxp3wt mice.
Notably, in spite of the deficiency in Treg development, mes-
enteric LN T cells of T-Bmc Foxp3sf mice did not become differ-
entiated Th1, Th2, or Th17 cells, as shown by the analysis of IL-4,
IFNg, and IL-17 transcripts (Figure 3C). We analyzed B cell acti-
vation and observed that the oral OVA treatment induced a small
increase in the percentage of FAS+B220+ cells in both Foxp3wt
and Foxp3sf mice (Figure S7).
These results show that oral OVA treatment induced a popula-
tion of adaptive Foxp3+ T cells in mesenteric LN of T-Bmc mice
but that even when it was not possible to generate Foxp3+ Treg
cells (because of the scurfy mutation), there was no induction of
effector Th functions. Our data support the view (Iweala and
Nagler, 2006) that the default response of the intestinal environ-
ment to innocuous antigens is noninflammatory.
Adaptive Foxp3+ Treg Cells Control the Severity
of Inflammation
The role of Foxp3+ Treg cells in sites of chronic inflammation is
not clear. Because there are few Treg cells in uninflammed tis-
sue, and many Treg cells in inflamed tissues, it is possible that
Treg cells contribute to the pathogenesis of inflammation or
that they are neutral because they are turned off in an inflamma-
tory environment. It is also possible that inflammation would be
worse if Foxp3+ Treg cells were not present at the sites. We
sought to take advantage of our experimental system to address
these possibilities.
We immunized T-Bmc Foxp3sf and Foxp3wtmicewith OVA-HA
in alum, a treatment that induces a strong Th2 and IgE response
in both types of mice, and subsequently administered OVA-HA
intranasally twice a week for eight weeks to create a chronic
stimulation (Figure 4A). We observed marked differences in
lung inflammation between wild-type mice and those carrying
scurfy Foxp3 genes. H&E-stained lung sections showed dense
perivascular and peribronchial cellular infiltrates in chronically
challenged T-Bmc Foxp3sf mice, whereas a greatly reduced in-
flammatory load was observed in Foxp3-competent T-Bmc
mice (Figure 4B). In fact, chronically challenged T-Bmc Foxp3wt
mice had less lung inflammation than mice with acute inflamma-
tion. In contrast, in T-Bmc Foxp3sf mice the degree of inflamma-
tion increased as the number of exposures to antigen increased
(Figure 4B).
The analysis of lung-infiltrating cells showed that chronically
challenged T-Bmc Foxp3sf mice had three to four times more
cells infiltrating the lungs than Foxp3wt mice (Figure 4C). The
number of CD4+ cells in lungs of Foxp3sf mice was about
5-fold higher than in lungs of chronically challenged Foxp3wt
mice, and the number of IL-4-producing cells was about
12-fold higher (Figure 4C). Consistent with the strict IL-4 depen-
dency of IgE, chronically challenged T-Bmc Foxp3sf mice had
Immunity
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Foxp3sf Mice
(A) Experimental protocol. T-Bmc Foxp3wt and T-Bmc Foxp3sf mice were ad-
ministered OVA in the drinking water for 5 days. Two and 20 days later themice
were sacrificed, and T and B cell responses were analyzed.
(B) Comparative analysis of CD69, CD45RB, CD25, CD103, and Foxp3 ex-
pression in CD4+ cells frommesenteric LN cells of T-Bmc Foxp3wt and Foxp3sf
mice treated with oral OVA (day 7).
(C) Oral OVA does not induce Th1, Th2, or Th17 cells in mesenteric LN of
T-Bmc Foxp3sf mice. Q-PCR analysis of IL-4, IFN-g, and IL-17 expression in
total LN cells from oral OVA-treated mice (days 7 and 25). For comparison,
samples from mesenteric LN cells of immunized mice (Imm) and from in vitro
differentiated Th1, Th2, and Th17 cells were also included. The results shown
are averages + SD of 2–3 mice per group. The data are representative of three
independent experiments.5-fold higher serum IgE than chronically challenged animals able
to generate Foxp3+Treg cells (Figure 4D), even though bothmice
strains generated comparable hyper-IgE responses in acute
phase.
The differences in IL-4 and IgE production in chronically chal-
lengedmice were confirmed through Q-PCR analysis of RNA ex-
pression in BAL cells, lungs, and draining LN (Figure 4E). We in-
cluded samples from immunized mice with acute inflammation
to examine the acute-to-chronic progression. We also analyzed
the expression of IL-10, a cytokine produced by Th2 and Tr1
cells; IL-33, a cytokine produced by lung epithelial cells that pro-
motes Th2 responses (Schmitz et al., 2005); and Fc3RI, which is
expressed by mast cells and basophils. In T-Bmc mice with in-
tact Foxp3 genes, the IL-4 mRNA production decreased signifi-
cantly from the acute to the chronic phase in thoracic LN and less
substantially in BAL cells and lungs. In contrast, IL-4mRNA was
upregulated several-fold from the acute to the chronic phase in
T-Bmc Foxp3sf mice (Figure 4E). A similar pattern of expression
was observed for IL-10. A large increase in mRNA for Fc3RI was
observed in chronically challenged T-Bmc Foxp3sfmice, indicat-
ing an increased number of mast cells and/or basophils. A much
lower increase in Fc3RImRNA was observed in chronically chal-
lenged mice with adaptive Foxp3 Treg cells (Figure 4E). Analysis
of IgE transcripts in lungs and draining LN yielded a rather similar
result. Production of IL-33mRNAwas also sustained in Treg-de-
ficient chronically challenged mice, whereas it was suppressed
in chronically challenged mice capable of generating adaptive
Foxp3+ Treg cells (Figure 4E). From these data we conclude
that, in situations of chronic antigen exposure, adaptive
Foxp3+ Treg cells have an important role in reducing IL-4 pro-
duction, IL-4 mediated pathology, and overall inflammation in
the lung.
Adaptive Foxp3+ Treg Cells Control Formation
of Ectopic Organized Lymphoid Tissue
A feature of many chronic inflammatory diseases is the ectopic
development of organized lymphoid tissue with defined T and
B cell areas and germinal centers (Aloisi and Pujol-Borrell,
2006; Drayton et al., 2006; Moyron-Quiroz et al., 2007). We
therefore investigated whether the dense lymphoid aggregates
found in the lungs of chronically challenged T-Bmc Foxp3sf
mice showed lymphoid tissue-organization. Indeed, lymphoid
aggregates with distinct T and B cell areas, including GL7+ ger-
minal centers, could be clearly identified in frozen lung sections
from T-Bmc Foxp3sf mice (Figure 5A). Furthermore, large num-
bers of IgE+ and IgG1+ cells localized to the lymphoid aggre-
gates, suggesting in situ class switching in the lungs
(Figure S8). Thus, in mice that lack naturally occurring as well
as adaptive Foxp3+ Treg cells, chronic antigen stimulation
through the airways leads to an abundance of organized lym-
phoid tissue in the lungs. Ectopic lymphoid tissue in the lungs
was much less abundant in mice able to generate adaptive
Foxp3+ Treg cells.
Given the amplified inflammation observed in T-Bmc Foxp3sf
mice compared to T-Bmc Foxp3wt mice, we studied whether
lung remodeling, a feature of chronic asthma, was increased in
mice deficient in Foxp3. We observed severe smooth-muscle
hypertrophy in blood vessels and, to a lesser degree, in the bron-
chia in T-Bmc Foxp3sf mice but observed much-less-intenseImmunity 29, 114–126, July 18, 2008 ª2008 Elsevier Inc. 119
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verity of chronic allergic inflammation is greatly reduced by the
presence of adaptive Foxp3+ Treg cells.
Adaptive Foxp3+ Treg Cells Control the Spreading
of IL-4-Producing Cells
Wenext assessedwhether the lack of adaptive Foxp3+ Treg cells
could result in spreading of the Th2 response from the airways
and lungs to other tissues during continuous exposure to OVA
via the nasal route. In fact, as the number of OVA instillations in-
creased, we noticed inflammation in the ears and other parts of
the skin only in T-Bmc Foxp3sf mice. We thus analyzed IL-4 pro-
duction by cells from the lungs, thoracic LN, mesenteric LN, and
spleen. Whereas in chronically exposed T-Bmc Foxp3wtmice we
could only detect large numbers of IL-4-producing cells in the
lungs, in equally treated T-Bmc Foxp3sfmicewe foundOVA-spe-
cific Th2 cells in distal LN as well as the spleen (Figure 6A). It is
worth noting that because the first immunization was intraperito-
neal (Figure 4A), during the acute response we also found OVA-
specific Th2 cells in spleen and mLN of T-Bmc Foxp3wt mice;
however, upon repeated intranasal challenge the presence of
OVA-specific Th2 cells became restricted to the lungs.
The control of the spreading of Th2 cells in the chronic phase
was paralleled by an increase in Foxp3+ Treg cells upon chronic
antigen stimulation. Q-PCR analysis of lung tissue and draining
LN showed that Foxp3 expression increased about 4- and 5-
fold, respectively, from the acute to the chronic phase. FACS
analysis of cells from the BAL showed a 2-fold increase in
the percentage of Foxp3+ cells within the T cell population
(Figure 6B). In sum, adaptive Foxp3 Treg expansion in chronic in-
flammation mediates a profound decrease in IL-4-producing
cells in proximal and distal lymphoid organs.
Foxp3-Independent Control of Eosinophilia
We next assessed IL-5 production and eosinophilia during the
acute and chronic phases in mice able or unable to generate
adaptive Foxp3+ Treg cells. We observed more than a 90% re-
duction of eosinophil numbers in the BAL of chronically chal-
lenged T-Bmc Foxp3wt mice compared with BAL from acute-
phase mice (Figure 7A). Chronically challenged T-Bmc Foxp3sf
mice also showed a significant reduction in eosinophilia com-
pared to acute-phase mice, although this reduction (75%) was
less pronounced than in T-Bmc Foxp3wt mice. Essentially the
same results were obtained by Q-PCR analysis with eosinophil
peroxidase (Figure 7B). Thus, eosinophilia can be controlled to
a significant extent in the absence of both naturally occurring
and adaptive Foxp3+ Treg cells.
Consistent with the reduced eosinophilia, we found that IL-5
mRNA expression was greatly reduced in BAL and thoracic LN
cells of chronically challenged mice irrespective of the presence
or absence of adaptive Foxp3+ T cells (Figure 7B). Intracellular
staining of IL-5 in lung-infiltrating T cells also showed marked re-
duction in the chronic phase compared to the acute phase
(Figure 7C). Thus, suppression of eosinophilia in chronically chal-
lenged mice is probably secondary to the suppression of IL-5
production and occurs even in the complete absence of
Foxp3+ Treg cells.
In order to investigate the mechanism of Foxp3+ Treg-inde-
pendent reduction in eosinophilia, we focused on IFN-g. We120 Immunity 29, 114–126, July 18, 2008 ª2008 Elsevier Inc.showed previously that the presence of small amounts of IFN-g
were important in reducing the amount of IL-5 production by
Th2 cells (Wensky et al., 2001). It has also been shown that
IFN-g suppressed eosinophilia during acute allergic inflamma-
tion in sensitized BALB/c mice (Iwamoto et al., 1993). If IFN-g
is critical for the reduction in eosinophils during chronic lung in-
flammation in a Foxp3+Treg-independent fashion, neutralization
of IFN-g should maintain the eosinophilia in Foxp3sf and Foxp3wt
mice. Indeed, injection of anti-IFN-g antibody weekly into T-Bmc
Foxp3wt or T-Bmc Foxp3sf mice exposed to chronic intranasal
antigen led to a 600% increase in the number of eosinophils in
the BAL (Figure 7D). These results support a role for IFN-g in
the Foxp3-independent control of eosinophilia.
DISCUSSION
We analyzed the importance of adaptive Foxp3+ Treg cells in
mucosal tolerance and in chronic allergic inflammation. We
found that the induction of Foxp3+ Treg cells was essential for
establishing tolerance through the respiratory and gut mucosa.
In chronic allergic inflammation, adaptive Foxp3+ Treg cells con-
trolled the severity of inflammation, IL-4-mediated pathology,
and the formation of organized lymphoid structures in the lungs.
In contrast, we found that IL-5 production and eosinophilia in
chronic inflammation were suppressed by IFN-g independently
of Foxp3.
To study the function of adaptive Foxp3+ Treg cells,we needed
to build an experimental mouse system in which the effect of
adaptive Foxp3+ Treg cells could be distinguished from that of
naturally occurring Foxp3+ Treg cells. These mice would have
conventional T cells but lack naturally occurring Treg cells. All
TCR transgenic Rag/mice described so far have conventional
T cells but lack natural Treg cells.Wefirst demonstrated the func-
tional absence of Treg cells in MBP TCR Tg Rag/ mice that
develop spontaneous autoimmune disease (Lafaille et al., 1994;
Olivares-Villagomez et al., 1998) and, much later, described the
absence of Foxp3+ T cells in these mice (Shen et al., 2005). The
lack of thymic-derived Foxp3+ T cells in TCR Tg Rag/ mice
was fundamental to the demonstration of in vivo peripheral con-
version of CD4+Foxp3 cells into functional CD4+Foxp3+ Treg
cells (Apostolou and von Boehmer, 2004) (Cobbold et al., 2004)
(Curotto de Lafaille et al., 2004; Mucida et al., 2005).
Although they solved one problem, the TCR Tg Rag/ ex-
perimental systems could be criticized because, by necessity,
they harbored a monoclonal T cell repertoire. It was thus impor-
tant that we establish that the same principles of adaptive
Foxp3+ Treg induction applied when the T cells derived from
TCR Tg Rag/ mice were a small minority in the context of
wild-type mice. Therefore, the experimental system used in
this manuscript reproduces the mucosal-tolerance-inductive
mechanisms that operate in wild-type mice with full lymphocyte
repertoires.
A second issue in the development of the experimental system
was to specifically eliminate adaptive Foxp3+ regulatory T cells.
By using the scurfy null allele of the Foxp3 gene crossed into TCR
Tg Rag/mice, we established mice that did not have naturally
occurring Treg cells (because they are TCR Tg Rag/) and that
could notmake adaptive Foxp3+ cells (because of the scurfymu-
tation). Comparing these mice to TCR Tg Rag/ mice that had
Immunity
Adaptive Foxp3+ Treg Cells in Allergic InflammationFigure 4. Immunized T-BmcMicewith Deficient Foxp3GenesDevelop Severe Lung Inflammation uponChronic Exposure to Antigen through
the Airways
(A) Experimental protocol for chronic antigen exposure. T-Bmcmice carrying wild-type (wt) or scurfy (sf) Foxp3 genes were immunized with OVA-HA in alum and
were subsequently administered intranasal OVA-HA twice a week for 8 weeks (chronic group). For acute inflammation, immunized mice were administered
OVA-HA intranasally three times.
(B) Representative H&E sections of lungs from immunized mice administered intranasal OVA-HA three times (acute) or during 8 weeks (chronic) and from un-
treated mice. Original magnification: 403.
(C) Cellular infiltrates in lungs of immunizedmice chronically exposed toOVA-HA. The graphics show the average andSDof total, CD4+, andCD4+IL-4+ lung-infiltrating
cells.Thedataare representativeof three independentexperiments. r: ratiobetweenaverageofchronicallychallengedFoxp3sfandchronicallychallengedFoxp3wtmice.
(D) IgE levels in sera from immunized mice administered OVA-HA intranasally for 8 weeks. Each dot corresponds to one mouse.
(E) Q-PCR analysis of IL-4, IgE, Fc3RI, IL-10, and IL-33mRNA expression in mice with acute (Ac) or chronic (Ch) lung inflammation and in untreated (Ut) mice car-
rying wild-type (w) or scurfy (s) Foxp3 genes. The results are averages + SD. n = 11 for Ch wt; n = 8 for Ch sf; n = 4–5 for Ac and Ut groups. ND: not done.
**p% 0.01; *p% 0.05.Immunity 29, 114–126, July 18, 2008 ª2008 Elsevier Inc. 121
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adaptive Treg cells. Using these paired mouse strains, we
showed that adaptive Foxp3+ Treg cells are essential for mu-
cosa-induced tolerance. Pretreatment of mice with OVA through
the gut or the airways induces immunological tolerance by
means of the TGF-b-dependent generation of adaptive Foxp3+
Treg cells. The adaptive Foxp3+ Treg cells that arise without
a concomitant development of effector Th cells (see below) are
extremely effective at preventing T and B cell responses to im-
munization. As a consequence, lung inflammation due to OVA
administered through the airways is also prevented. Thus, the
lack of pre-existing adaptive Foxp3+ Treg cells at the time of im-
munization in mucosal-OVA-treated T-Bmc Foxp3sfmice results
in their allergic sensitization.
In the absence of adaptive Foxp3+ Treg cells, the Th2 and IgE
responses of orally treated T-Bmc Foxp3sf mice were of the
same magnitude as the responses in T-Bmc Foxp3wt mice to
which no mucosal tolerance protocol was applied. Thus, in the
absence of adaptive Foxp3+ Treg cells, Foxp3-independent
mechanisms of mucosal tolerance did not contribute to the re-
duction of Th2-mediated responses. Given the fact that other
T cells, such as Th3 cells (Fukaura et al., 1996), have been shown
to be important in oral tolerance, it is likely that these cells oper-
ate in the same pathway as adaptive Foxp3+ Treg cells; for in-
stance, Th3 cells could supply the TGF-b that is necessary for
the in vivo generation of oral-tolerance-derived Foxp3+ Treg
cells (Carrier et al., 2007; Mucida et al., 2005).
Figure 5. Lymphoid Neogenesis and
Smooth-Muscle Remodeling in Lungs of
Chronically Challenged T-Bmc Foxp3sfMice
(A) Frozen lung sections from T-Bmc Foxp3sfmice
chronically exposed to OVA-HA were stained with
antibodies to the DO11.10 TCR (KJ1-26), to B cells
(B220), and to germinal-center cells (GL7). Nuclei
were stained with DAPI.
(B) Smooth-muscle hypertrophy in chronically
challenged T-Bmc mice. Frozen lung sections
were stained with antibodies against a-smooth
muscle actin (a-SMA) for visualization of smooth
muscle and with anti-CD31 (PECAN-1) for visuali-
zation of vascular endothelium. Nuclei were
stained with DAPI.
Representative sections are shown. Magnifica-
tion: 1003. B: bronchia; V: vessels.
Although oral OVA per se did not in-
duce tolerance in Foxp3-deficient T-Bmc
mice, it did not induce effector functions
either; no increase in the Th1, Th2, or
Th17 cytokines was observed. This was
striking in consideration of the fact that
the mesenteric LN T cells upregulated
CD69, an indication of antigen-mediated
activation. Because TGF-b is required for
the development of both adaptive Treg
and Th17 cells, it was postulated that
there is a reciprocal pathway leading to ei-
ther Th17 or Treg cells (Bettelli et al.,
2006). Thus, a higher percentage of Th17
cells could have been expected in the absence of Foxp3, but
this was not the case. Our data are consistent with the idea that
different intestinal microenvironments give rise to Th17 cells
and Treg cells (Coombes et al., 2007; Denning et al., 2007; Mu-
cida et al., 2007; Sun et al., 2007) and support the view that, in
the absence of adjuvant factors, oral antigen is presented in ami-
croenvironment that can only give rise to Treg cells.
We studied the proliferation and accumulation of Treg cells
during the onset of lung inflammation. We observed that adap-
tive Foxp3+ T cells had a higher proliferation rate in vivo than
non-Treg CD4+ cells of identical specificity. Other laboratories
have observed robust proliferation of Treg cells in vivo (Annacker
et al., 2001; Klein et al., 2003;Walker et al., 2003). However these
preceding studies did not focus on Treg cells in inflamed tissues,
where Treg accumulation is the highest.
We also found a different homing pattern of Treg cells and con-
ventional CD4+ T cells into the airways. In non-immunized T-Bmc
mice the vast majority of T cells display a naive phenotype, and
very few CD4+ T cells are found in the BAL. Upon intraperitoneal
immunization, T cells with activated and memory phenotypes,
but not Foxp3+ T cells, are found in the BAL. Only after intranasal
challenge with antigen is it that a substantial proportion of
Foxp3+ Treg cells make their way across the lung epithelium
into the airways.
During chronic allergic exposure through the airways, adaptive
Foxp3+ Treg cells became overrepresented in the CD4+ popula-
tion of the inflamed tissue and affected the evolution of122 Immunity 29, 114–126, July 18, 2008 ª2008 Elsevier Inc.
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diated a marked reduction of cytokine production in lungs and
lymphoid organs and a reduction of cellular inflammation in the
lungs. Interestingly, the resolution of lung inflammation in immu-
nized wild-type BALB/c mice chronically exposed to antigen fol-
lows a similar pattern (Shinagawa and Kojima, 2003; also data
not shown). We called this phenomenon ‘‘post-sensitization reg-
ulation’’ because it occurs after the onset of Th2 inflammation. In
contrast, mucosal tolerance prevents the development of effec-
tor cytokine-producing Th cells altogether.
Post-sensitization regulation in the chronic phases also
involved decreased IL-5 production and eosinophilia, but this
occurred in mice that developed Foxp3+ Treg cells as well as in
Foxp3-deficient mice. We found that the decreased eosinophilia
was dependent on IFN-g; antibody neutralization of IFN-g re-
stored high eosinophil numbers in both mouse strains.
Our laboratory showed that IFN-g selectively regulates IL-5
production in differentiating Th2 cells without interfering with
IL-4 production (Wensky et al., 2001). Thus, in chronically chal-
lenged mice with no Foxp3+ Treg cells, IFN-gmight affect newly
differentiating Th2 cells by suppressing IL-5 production while
maintaining IL-4 production. Another possible explanation for
the dissociation between IL-4 and IL-5 production in the chron-
ically challenged T-Bmc Foxp3sf mice is that many of the IL-4-
producing cells in inflamed tissue are cells that would have
Figure 6. Disseminated IL-4 Production in
Lymphoid Organs of Chronically Chal-
lenged Mice with No Adaptive Treg Cells
(A) Widespread presence of IL-4-producing cells
in secondary lymphoid organs of chronically chal-
lenged T-Bmc Foxp3sf mice. IL-4 production was
analyzed by flow cytometry in cells from lung,
thoracic LN, mesenteric LN, and spleen from
chronically challenged (Ch) and from untreated
(Ut) T-Bmc mice. The figure shows representative
plots of gated TCR+ (KJ1-26+) cells. The bar
graphic on the right shows averages + SD of
IL-4-producing cells within the KJ1-26+ population
(two to four mice per group).
(B) Upper section: Q-PCR analysis of Foxp3 ex-
pression in lung and thoracic LN of mice with
acute (Ac) or chronic (Ch) inflammation and
from untreated (Ut) mice. Values are averages +
SD. Numbers of mice per group are as in
Figure 4E. Lower section: Representative dot
plots show expression of Foxp3 and CD25 in
CD4+ BAL cells from mice with acute and chronic
inflammation. The bar graphic on the right shows
the average + SD values (n = 4 mice per group).
*p % 0.05.
become Foxp3+ if they had a normal
Foxp3 gene (Williams and Rudensky,
2007). Finally, it is also possible that the
cellular sources of IL-4 and IL-5 change
from the acute to the chronic phases
and that cells other than Th2 cells, such
as mast cells and basophils, make
a greater contribution to IL-4 production
at the chronic stages.
The issue of whether adaptive Foxp3+ Treg cells and naturally
occurring Foxp3+ Treg cells have overlapping or distinct func-
tions remains unresolved. It is tempting to speculate that there
is a division of labor between both types of Foxp3+ Treg cells.
It is believed that naturally occurring Treg cells are selected in
the thymus by high-avidity ligands. The T cell receptor repertoire
of naturally occurring Treg cells is likely to be biased toward li-
gands that are present in the thymus, and naturally occurring
Treg cells are crucial in self-tolerance. In contrast, adaptive
Foxp3+ Treg cells are selected in the thymus in the same avidity
window as naive CD4+ T cells and share the TCR repertoire with
all other peripheral Foxp3 T cells that respond to antigens not
present in the thymus. Such adaptive Foxp3+ Treg cells are ex-
pected to play a key role in limiting immune-mediated tissue
damage that arises upon chronic exposure to non-self antigens,
such as environmental allergens or chronic infections. In this
manuscript we have shown that this role can, indeed, be played
by adaptive Foxp3+ Treg cells.
EXPERIMENTAL PROCEDURES
Mice and Antigen Treatment
T-B monoclonal mice (T-Bmc) (Curotto de Lafaille et al., 2001) carrying wild-
type and scurfy Foxp3 genes in a BALB/c background were bred in the SPF
animal facility at the Skirball Institute, NYUSM. Scurfy and BALB/c mice
were purchased from The Jackson Laboratories and Taconic. Foxp3gfp.KIImmunity 29, 114–126, July 18, 2008 ª2008 Elsevier Inc. 123
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Adaptive Foxp3+ Treg Cells in Allergic InflammationFigure 7. Treg-Independent Suppression of Eosinophilic Inflammation and IL-5 Production in Mice with Chronic Inflammation
(A) Eosinophil numbers in the BAL of immunizedmice administered OVA-HA intranasally three times (acute) or for eight weeks (chronic) as described in Figure 4A.
(B) Q-PCR analysis of eosinophil peroxidase (EPX) and IL-5mRNA expression in mice with acute (Ac) or chronic (Ch) lung inflammation and in untreatedmice (Ut).
Numbers of mice per group are as in Figure 4E.
(C) Decreased IL-5 production in mice with chronic lung inflammation. IL-5 production was analyzed ex vivo in lung-infiltrating cells from mice with acute or
chronic inflammation and from untreated mice. The figure shows representative plots of IL-5 staining in gated TCR+ (KJ1-26+) cells.
(D) IFN-g suppresses eosinophilic inflammation in chronically challengedmice. Immunizedmicewere treated for 5 weekswith intranasal OVA-HA, and during that
period they were injected with anti-IFN-g antibodies. The figure shows the n-fold change in BAL eosinophil numbers in antibody-treated mice. n = 3 for Ch wt and
Ch wt IFN-g; n = 4 for Ch sf and Ch sf IFN-g.
(A, B, and D) Data are averages + SD. **p% 0.01; *p% 0.05.reporter (Korn et al., 2007) was backcrossed to the T-Bmc mice in a BALB/
c background for four generations. Oral and airway tolerance to chicken ov-
albumin (OVA) were induced as described (Mucida et al., 2005). For immu-
nization, mice were injected with 100 mg OVA-HA in 1 mg of alum by intra-
peritoneal route. To induce acute lung inflammation, we administered 10 mg
of OVA-HA by intranasal route three times. To determine T cell proliferation
rates, we injected mice with 3 mg of BrdU by combined intraperitoneal and
intravenous routes 6 hr before analysis. To induce chronic lung inflamma-
tion, we administered 10 mg of OVA-HA twice a week for 8 weeks. To neu-
tralize IFN-g, we injected immunized mice with 1 mg of the antibody XMG.1
by intraperitoneal route once a week, beginning one day before the first in-
tranasal treatment. BAL collection and analysis and lung histology were per-
formed as described (Mucida et al., 2005). All mouse procedures were ap-
proved by the New York University Institutional Animal Care Use
Committee.
Mononuclear Cell Isolation and Flow Cytometry
BAL, LN, and spleen mononuclear cell suspensions were prepared as de-
scribed (Curotto de Lafaille et al., 2001; Mucida et al., 2005). To obtain infiltrat-
ing lung cells, we digested lungs from perfused mice with liberase blendzyme
(Roche) and purified the infiltrating cells over 38% Percoll (Amersham Biosci-
ences). Cytokine-producing cells were detected by flow cytometry after ex-
vivo stimulation with PMA and Ionomycin. Staining of Foxp3, BrdU, and cyto-
kines was performed on fixed and permeabilized cells. Data were acquired in
a FACS Calibur (BD Biosciences) and analyzed with FlowJo software (Tree
Star).124 Immunity 29, 114–126, July 18, 2008 ª2008 Elsevier Inc.Quantitative PCR Analysis
RNAwas extractedwith TRIzol (Invitrogen). cDNA synthesis and real-time PCR
were performed by standard procedures. Expression values were normalized
to b-actin. Most oligonucleotide sequences have been described previously
(Curotto de Lafaille et al., 2004; Erazo et al., 2007; Ivanov et al., 2006; Mucida
et al., 2005). Additional sequences are provided in the Supplemental Data.
Lung Immunohistology
Frozen lung sections were fixed with acetone, blocked, stained, and analyzed
as described (Erazo et al., 2007).
Statistical Analysis
A two-tailed Student’s t test was used for comparisons. p values% 0.05 were
considered statistically significant.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures and eight
figures and can be found with this article online at http://www.immunity.com/
cgi/content/full/29/1/114/DC1/.
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